Purple Biotech earnings were $26.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PPBT earnings report on Mar 31, 2026 announced Q1 2026 earnings of $86.0k, down 99.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PPBT reported annual earnings of $26.4M, with 264.4% growth.
On PPBT's earnings call on Invalid Date, Purple Biotech (NASDAQ: PPBT) reported Q1 2026 earnings per share (EPS) of N/A, up N/A year over year. Total PPBT earnings for the quarter were $86.00 thousand. In the same quarter last year, Purple Biotech's earnings per share (EPS) was N/A.
As of the last Purple Biotech earnings report, Purple Biotech is currently profitable. Purple Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $26.02 million, a 561.89% increase year over year.
What was PPBT's earnings growth in the past year?
As of Purple Biotech's earnings date in Invalid Date, Purple Biotech's earnings has grown year over year. PPBT earnings in the past year totalled $26.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.